Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1983 Mar;45(3):1228–1234. doi: 10.1128/jvi.45.3.1228-1234.1983

Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

C Glaubiger, K Nazerian, L F Velicer
PMCID: PMC256539  PMID: 6300460

Abstract

Marek's disease herpesvirus A antigen (MDHV-A) was identified as a 61,000- to 65,000-dalton glycoprotein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after immunoprecipitation from the culture medium of both [35S]methionine- and [14C]glucosamine-labeled infected cells by specific rabbit serum directed against MDHV-A. Rigorous identification was accomplished by selective blocking of this specific immunoprecipitation of the glycoprotein with purified MDHV-A that was isolated at its characteristic isoelectric point. These results identify and characterize MDHV-A in terms of the previously determined physical and chemical properties of the antigen. A molecule of similar size was immunoprecipitated from the culture medium of cells infected with herpesvirus of turkeys, extending previous observations about the identity of a potentially important common antigen shared by MDHV and the nonpathogenic vaccine virus, herpesvirus of turkeys.

Full text

PDF
1228

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonner W. M., Laskey R. A. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem. 1974 Jul 1;46(1):83–88. doi: 10.1111/j.1432-1033.1974.tb03599.x. [DOI] [PubMed] [Google Scholar]
  2. Chen J. H., Purchase H. G. Surface antigen on chick kidney cells infected with the herpesvirus of Marek's disease. Virology. 1970 Feb;40(2):410–412. doi: 10.1016/0042-6822(70)90421-6. [DOI] [PubMed] [Google Scholar]
  3. Churchill A. E., Chubb R. C., Baxendale W. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J Gen Virol. 1969 Jun;4(4):557–564. doi: 10.1099/0022-1317-4-4-557. [DOI] [PubMed] [Google Scholar]
  4. Graves D. C., Velicer L. F. Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides. J Virol. 1974 Aug;14(2):349–365. doi: 10.1128/jvi.14.2.349-365.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ikuta K., Nishi Y., Kato S., Hirai K. Immunoprecipitation of Marek's disease virus-specific polypeptides with chicken antibodies purified by affinity chromatography. Virology. 1981 Oct 15;114(1):277–281. doi: 10.1016/0042-6822(81)90277-4. [DOI] [PubMed] [Google Scholar]
  6. Kaaden O. R., Dietzschold B. Alterations of the immunological specificity of plasma membranes from cells infected with Marek's disease and turkey herpes viruses. J Gen Virol. 1974 Oct;25(1):1–10. doi: 10.1099/0022-1317-25-1-1. [DOI] [PubMed] [Google Scholar]
  7. Kaaden O. R., Dietzschold B., Ueberschär S. Vaccination against Marek's disease: immunizing effect of purified turkey herpes virus and cellular membranes from infected cells. Med Microbiol Immunol. 1974 Jun 19;159(4):261–269. doi: 10.1007/BF02123735. [DOI] [PubMed] [Google Scholar]
  8. Kessler S. W. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol. 1975 Dec;115(6):1617–1624. [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lee Y. S., Tanaka A., Silver S., Smith M., Nonoyama M. Minor DNA homology between herpesvirus of turkey and Marek's disease virus? Virology. 1979 Feb;93(1):277–280. doi: 10.1016/0042-6822(79)90299-x. [DOI] [PubMed] [Google Scholar]
  12. Lesnik F., Ross L. J. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus. Int J Cancer. 1975 Jul 15;16(1):153–163. doi: 10.1002/ijc.2910160117. [DOI] [PubMed] [Google Scholar]
  13. Long P. A., Clark J. L., Velicer L. F. Marek's Disease Herpesviruses II. Purification and Further Characterization of Marek's Disease Herpesvirus A Antigen. J Virol. 1975 May;15(5):1192–1201. doi: 10.1128/jvi.15.5.1192-1201.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Long P. A., Kaveh-Yamini P., Velicer L. F. Marek's Disease Herpesviruses I. Production and Preliminary Characterization of Marek's Disease Herpesvirus A Antigen. J Virol. 1975 May;15(5):1182–1191. doi: 10.1128/jvi.15.5.1182-1191.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murthy K. K., Calnek B. W. Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens. Infect Immun. 1979 Nov;26(2):547–553. doi: 10.1128/iai.26.2.547-553.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nazerian K., Chen J. H. Immunoferritin studies of Marek's disease virus directed intracellular and membrane antigens. Arch Gesamte Virusforsch. 1973;41(1):59–65. doi: 10.1007/BF01249929. [DOI] [PubMed] [Google Scholar]
  17. Okazaki W., Purchase H. G., Burmester B. R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 1970 May;14(2):413–429. [PubMed] [Google Scholar]
  18. Payne L. N., Powell P. C., Rennie M. C., Ross L. J. Studies on the mechanism of vaccinal immunity to Marek's disease. Comp Immunol Microbiol Infect Dis. 1978;1(1-2):31–36. doi: 10.1016/0147-9571(78)90007-3. [DOI] [PubMed] [Google Scholar]
  19. Powell P. C., Rowell J. G. Dissociation of antiviral and antitumor immunity in resistance to Marek's disease. J Natl Cancer Inst. 1977 Sep;59(3):919–924. doi: 10.1093/jnci/59.3.919. [DOI] [PubMed] [Google Scholar]
  20. Purchase H. G., Okazaki W., Burmester B. R. Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease. Avian Dis. 1972 Apr;16(1):57–71. [PubMed] [Google Scholar]
  21. Ross L. J., Basarab O., Walker D. J., Whitby B. Serological relationship between a pathogenic strain of Marek's disease virus, its attenuated derivative and herpes virus of turkeys. J Gen Virol. 1975 Jul;28(1):37–47. doi: 10.1099/0022-1317-28-1-37. [DOI] [PubMed] [Google Scholar]
  22. Ross L. J., Biggs P. M., Newton A. A. Purification and properties of the 'A' antigen associated with Marek's disease virus infections. J Gen Virol. 1973 Mar;18(3):291–304. doi: 10.1099/0022-1317-18-3-291. [DOI] [PubMed] [Google Scholar]
  23. Spear P. G. Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J Virol. 1976 Mar;17(3):991–1008. doi: 10.1128/jvi.17.3.991-1008.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Van Zaane D., Brinkhof J. M., Gielkens A. L. Molecular-biological characterization of Marek's disease virus. II. Differentiation of various MDV and HVT strains. Virology. 1982 Aug;121(1):133–146. doi: 10.1016/0042-6822(82)90123-4. [DOI] [PubMed] [Google Scholar]
  25. Van Zaane D., Brinkhof J. M., Westenbrink F., Gielkens A. L. Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology. 1982 Aug;121(1):116–132. doi: 10.1016/0042-6822(82)90122-2. [DOI] [PubMed] [Google Scholar]
  26. Velicer L. F., Yager D. R., Clark J. L. Marke's disease herpesviruses. III. Purification and characterization of Marek's disease herpesvirus B antigen. J Virol. 1978 Jul;27(1):205–217. doi: 10.1128/jvi.27.1.205-217.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  28. Witte O. N., Wirth D. F. Structure of the murine leukemia virus envelope glycoprotein precursor. J Virol. 1979 Feb;29(2):735–743. doi: 10.1128/jvi.29.2.735-743.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Witter R. L., Nazerian K., Purchase H. G., Burgoyne G. H. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res. 1970 Mar;31(3):525–538. [PubMed] [Google Scholar]
  30. Wyn-Jones A. P., Kaaden O. R. Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys. Infect Immun. 1979 Jul;25(1):54–59. doi: 10.1128/iai.25.1.54-59.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES